Analyses of microsatellite instability and the transforming growth factor-β receptor type II gene mutation in sporadic breast cancer and their correlation with clinicopathological features

Breast Cancer Research and Treatment

Volumn 53, Issue 1, 1999, Pages 33-39

  Tomita, Shuji ^a   Deguchi, Shigeru ^a   Miyaguni, Takao ^a   Muto, Yoshihiro ^a   Tamamoto, Tohru ^a   Toda, Takayoshi ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Breast cancer; Clinicopathological features; Microsatellite instability; Prognosis; TGF RII gene

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; BREAST CANCER; CANCER SURVIVAL; CLINICAL FEATURE; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; PATHOLOGY; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

BREAST NEOPLASMS; DNA PRIMERS; DNA, NEOPLASM; FEMALE; HUMANS; MICROSATELLITE REPEATS; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA;

EID: 0032974195     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006167210269     Document Type: Article

References (30)

1. Thibodeau SN, Bren G, Schaid D: Microsatellite instability in cancer of the proximal colon. Science 260: 816-819, 1993
2. Aaltonen LA, Peltomaki P, Leach F, Sistonen P, Pylkkanen L, Mecklin J-P, Jarvinen H, Powell MS, Jen J, Hamilton RS, Petersen MG, Kinzler WK, Vogelstein B, Chapelle A: Clues to the pathogenesis of familial colorectal cancer. Science 260: 812-816, 1993
3. Risinger JI, Berchuck A, Kohler MF, Watson P, Lynch H, Boyd J: Genetic instability of microsatellites in endometrial carcinoma. Cancer Res 53: 5100-5103, 1993
4. Peltomaki P, Lothe RA, Aaltonen LA, Pylkkanen L, Lahti NM, Seruca R, David L, Holm R, Ryberg D, Haugen A, Brogger A, Borresen A-L, Chapelle A.: Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome. Cancer Res 53: 5853-5855, 1993
5. Lothe RA, Peltomaki P, Meling GI, Aaltonen LA, Nystrom-Lahti M, Pylkkanen L, Heimdal K, Andersen TI, Moller P, Rognum TO, Fossa SD, Haldorsen T, Langmark F, Brogger A, de la Chapelle A, Borresen A-L: Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res 53: 5849-5852, 1993
6. Honchel R, Hailing KC, Schaid DJ, Pittelkow M, Thibodeau SN: Microsatellite instability in Muir-Torre syndrome. Cancer Res 54: 1159-1163, 1994
7. Risio M, Reato G, Celle PF, Fizzotti M, Rossini FP, Foa R: Microsatellite instability is associated with the histological features of the tumor in nonfamilial colorectal cancer. Cancer Res 56: 5470-5474, 1996
8. Seruca R, Santos NR, David L, Constancia M, Barroca H, Carneiro F, Seixas M, Peltomaki P, Lothe R, Sobrinho-Simoes M: Sporadic gastric carcinomas with microsatellite instability display a particular clinicopathologic profile. Int J Cancer 64: 32-36, 1995
9. Paulson TG, Wright FA, Parker BA, Russack V, Wahl GM: Microsatellite instability correlates with reduced survival and poor disease prognosis in breast cancer. Cancer Res 56: 4021-4026, 1996
10. Wrana JL, Attisano L, Weiser R, Ventura F, Massague J: Mechanism of activation of the TGF-β receptor. Nature 370: 341-347, 1994
11. Alexandrow MG, Moses HL: Transforming growth factor-β and cell cycle regulation. Cancer Res 55: 1452-1457, 1995
12. Massague J: The transforming growth factor-β family. Annu Rev Cell Biol 6: 597-641, 1990
13. MacKay SLD, Yaswen LR, Tarnuzzer RW, Moldawer LL, Bland KI, Copeland EM, Schultz GS: Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: Correlation with sensitivity to growth inhibition by TGF-β. Ann Surg 221: 767-777, 1995
14. Filmus J, Kerbel RK: Development of resistance mechanisms to the growth-inhibitory effects of transforming growth factor-β during tumor progression. Opin Oncol 5: 123-129, 1993
15. Geiser AG, Burmester JK, Webbink R, Roberts BA, Sporn BM: Inhibition of growth by transforming growth factor-β following fusion of two nonresponsive human carcinoma cell lines. J Biol Chem 267: 2588-2593, 1992
16. Sun L, Wu G, Willson JK, Zhorowska E, Yang J, Rajkarunanayake I, Wang J, Gentry LE, Wang XF, Brattain MG: Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J Biol Chem 269: 26449-26455, 1994
17. Park K, Kim SJ, Bang Y, Park JG, Kim NK, Roberts AB, Sporn MB: Colon cancer cells that are not growth inhibited by TGF-β lack functional type I and type II TGF-β receptors. Proc Natl Acad Sci 91: 8772-8776, 1994
18. Markowitz S, Wang J, Myeroff L, Persons R, Sun L, Lutterbaugh J, Fan SR, Zborowska E, Kinzler WK, Vogelstein B, Brattain M, Willson KVJ: Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268: 1336-1338, 1994
19. Lu SL, Akiyama Y, Nagasaki H, Saitoh K, Yuasa Y: Mutations of the transforming growth factor-β type II receptor gene and genomic instability in hereditary nonpolyposis colorectal cancer. Biochem Biophys Res Commun 216: 452-457, 1995
20. Parsons R, Myeroff LL, Liu B, Willson JK, Markowitz SD, Kinzler KW, Vogelstein B: Microsatellite instability and mutations of the transforming growth factor-β type II receptor gene in colorectal cancer. Cancer Res 55: 5548-5550, 1995
21. Myeroff LL, Parsons R, Kim SJ, Hedrick L, Cho KR, Orth K, Mathis M, Kinzler KW, Lutterbaugh J, Park K: A transforming growth factor β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res 55: 5545-5547, 1995
22. Vincent F, Hagiwara K, Ke Y, Stoner DG, Demetrick JD, Bennett PW: Mutation analysis of the transforming growth factor β type II receptor in sporadic human cancers of the pancreas, liver, and breast. Biochem Biophys Res Commun 223: 561-564, 1996
23. Hori H, Miyake S, Akiyama Y: Clonal heterogeneity in human esophageal squamous cell carcinomas on DNA analysis. Jpn J Cancer Res 87: 923-929, 1996
24. Togo G, Toda N, Kanai F, Kato N, Shiratori Y, Kishi K, Imazeki F, Makuuchi M, Omata M: A transforming growth factor β type II receptor gene mutation common in sporadic cecum cancer with microsatellite instability. Cancer Res 56: 5620-5623, 1996
25. Martinsson T, Sjoberg RM, Hedborg F, Kogner P: Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short tandem repeat polymorphisms. Cancer Res 55: 5681-5686, 1995
26. Yee CJ, Roodi N, Verrier CS, Parl FF: Microsatellite instability and loss of heterozygosity in breast cancer. Cancer Res 54: 1641-1644, 1994
27. Aldaz CM, Chen T, Sahin A, Cunningham J, Bondy M: Comparative allelotype of in situ and invasive human breast cancer: high frequency of microsatellite instability in lobular breast carcinomas. Cancer Res 55: 3976-3981, 1995
28. Ji H, Stout LE, Zhang Q, Zhang R, Leung HT, Leung BS: Absence of transforming growth factor-β responsiveness in the tamoxifen growth-inhibited human breast cancer cell line CAMA-1. J Cell Biochem 54: 332-342, 1994
29. Kalkhoven E, Beraldi E, Panno ML, De Winter JP, Thijssen JHH, Van Der Burg B: Growth inhibition by anti- estrogens and progestins in TGF-β-resistant and -sensitive breast-tumor cells. Int J Cancer 65: 682-687, 1996
30. Koli KM, Ramsey TT, Ko Y, Dugger TC, Brattain MG, Arteaga CL: Blockade of transforming growth factor-β signaling does not abrogate antiestrogen-induced growth inhibition of human breast carcinoma cells. J Biol Chem 272: 8296-8302, 1997